setmelanotide (RM-493)

setmelanotide · Rhythm Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for setmelanotide (RM-493), covering 2017-04-20 to 2017-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Effects of RM-493 on Energy Expenditure in Obese Individuals [Phase 1]